Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes is a research paper published in Arthritis Research & Therapy (2022). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: AR073324
National Institutes of Health
Grant: T32AR064194
National Institutes of Health
Grant: DK126944
National Institutes of Health
Grant: AR060772
National Institutes of Health
Grant: AR075990
NIAMS NIH HHS
Grant: R01 AR073324
NIDDK NIH HHS
Grant: R01 DK126944
BLRD VA
Grant: I01 BX002234
National Institutes of Health
Grant: 5R21AR075990-02
Novel Synovial Role in Pathogenesis of Gout
National Institutes of Health
Grant: 1R01DK126944-01
Regulation of fatty acid metabolism in adipocytes
National Institutes of Health
Grant: 5T32AR064194-03
Rheumatic Diseases Research Training Grant
National Institutes of Health
Grant: 3P50AR060772-09S1
INvestigations In Gout, Hyperuricemia, and comorbidiTies (INSIGHT) Center of Research Translation (CORT)
National Institutes of Health
Grant: 5R01AR073324-02
Targeting hexokinase-2 in rheumatoid arthritis
Veterans Affairs San Diego Healthcare System
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals